Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far
Open Access
- 28 April 2022
- journal article
- review article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 9 (5), 584-593
- https://doi.org/10.1002/mdc3.13461
Abstract
Background The Coronavirus disease 2019 (Covid-19) pandemic has fueled both research and speculation, as to whether it could be a "perfect storm" for a post-Covid emergence of parkinsonism in some susceptible individuals, analogous to the post-encephalitic parkinsonism reported after the 1918 influenza epidemic. This theory is further augmented by reports of a pathogenic effect of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) on the central nervous system with specific impact on the dopaminergic pathway, as well as the possibility of the virus to selectively bind to Angiotensin-Converting Enzyme-2 (ACE-2); these molecules are expressed abundantly in the midbrain dopamine neurons and, are likely involved in several cellular mechanisms cited in Parkinson's Disease (PD) pathophysiology. Objectives-Methods Therefore, we performed a review of the literature up to February 2022 to explore the current landscape considering published cases of new-onset parkinsonism after a SARS-CoV-2 infection in otherwise healthy individuals. We summarized their clinical features, diagnostic and treatment approaches, discussing potential underlying mechanisms in light of PD pathogenesis theories. Results Twenty cases that developed parkinsonian features simultaneously or shortly after a reported SARS-CoV-2 infection were reviewed. In 11 of them, parkinsonism appeared in the context of encephalopathy, while four patients developed post-infectious parkinsonism without encephalopathy, and four bore similarities to idiopathic PD. Nine patients exhibited a good response to dopaminergic therapy, while four responded to immunomodulatory treatment. Conclusions Available data does not yet justify a clear association between the Covid-19 pandemic and a parkinsonism wave. However, vigilance is necessary, as long-term effects might have not been revealed.Keywords
This publication has 75 references indexed in Scilit:
- Caudo‐rostral brain spreading of α‐synuclein through vagal connectionsEMBO Molecular Medicine, 2013
- The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's diseaseFrontiers in Computational Neuroscience, 2013
- CNS infections, sepsis and risk of Parkinson's diseaseInternational Journal of Epidemiology, 2012
- Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuriesParkinsonism & Related Disorders, 2010
- FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitisJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Viral parkinsonismBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Parkinson's disease: a dual‐hit hypothesisNeuropathology and Applied Neurobiology, 2007
- Multiple hit hypotheses for dopamine neuron loss in Parkinson's diseaseTrends in Neurosciences, 2007
- The Vagus Nerve is One Route of Transneural Invasion for Intranasally Inoculated Influenza A Virus in MiceVeterinary Pathology, 2004
- Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunityBrain, 2004